Adverum Clinical Site 161 — Royal Oak, Michigan

Adverum Clinical Site 161 is a clinical research site located in Royal Oak, Michigan, United States 48073.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Adverum Clinical Site 161 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Neovascular Age-related Macular Degeneration.

Sponsors: Adverum Biotechnologies, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Adverum Clinical Site 161?

Adverum Clinical Site 161 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Adverum Clinical Site 161 conducted?

Adverum Clinical Site 161 has 1 clinical trials on record, with 1 currently active. Their work covers Neovascular Age-related Macular Degeneration.

Is Adverum Clinical Site 161 accredited by Crixeo Health?

Adverum Clinical Site 161 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Adverum Clinical Site 161?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.